Treatment of early uterine sarcomas: Disentangling adjuvant modalities

World Journal of Surgical Oncology

Volumn 7, Issue , 2009, Pages 38-

  Zagouri, Flora ^a   Dimopoulos, Athanasios Meletios ^a   Fotiou, Stelios ^b   Kouloulias, Vassilios ^c   Papadimitriou, Christos A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GEMCITABINE; GESTAGEN; GONADORELIN DERIVATIVE; IFOSFAMIDE; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; PACLITAXEL; PLATINUM DERIVATIVE; TRABECTEDIN; VINCRISTINE;

ABDOMINAL HYSTERECTOMY; ADJUVANT THERAPY; ANTINEOPLASTIC ACTIVITY; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CARCINOSARCOMA; CLINICAL TRIAL; CONTINUOUS INFUSION; CYTOREDUCTIVE SURGERY; DRUG RECEPTOR BINDING; ENDOMETRIUM SARCOMA; HORMONAL THERAPY; HUMAN; LAPAROTOMY; LEIOMYOSARCOMA; LEUKOPENIA; LYMPH NODE DISSECTION; MULTIPLE CYCLE TREATMENT; REVIEW; SALPINGOOOPHORECTOMY; SOFT TISSUE SARCOMA; UTERUS SARCOMA;

CARCINOSARCOMA; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LEIOMYOSARCOMA; SARCOMA; SARCOMA, ENDOMETRIAL STROMAL; UTERINE NEOPLASMS;

EID: 65449171696     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-7-38     Document Type: Review

References (106)

1. Salazar OM Bonfiglio TA Patten SF Keller BE Feldstein M Dunne ME Rudolph J Uterine sarcomas: Natural history, treatment and prognosis Cancer 1978, 42:1152-60 698910
2. Nordal RR Thoresen SO Uterine sarcomas in Norway 1956-1992: Incidence, survival and mortality Eur J Cancer 1997, 33:907-11 9291814
3. Harlow BL Weiss NS Lofton S The epidemiology of sarcomas of the uterus J Natl Cancer Inst 1986, 76:399-402 3456457
4. Papadimitriou CA Zorzou MP Markaki S Rodolakis A Voulgaris Z Bozas G Kastritis E Bamias A Gika D Dimopoulos MA Anthracycline-based adjuvant chemotherapy in early-stage uterine sarcomas: Long-term results of a single institution experience Eur J Gynaecol Oncol 2007, 28:109-16 17479671
5. Jonson AL Bliss RL Truskinovsky A Judson P Argenta P Carson L Dusenbery K Downs LS Jr Clinical features and outcomes of uterine and ovarian carcinosarcoma Gynecol Oncol 2006, 100, 561-4 16271748
6. Berchuck A Rubin SC Hoskins WJ Saigo PE Pierce VK Lewis JL Jr Treatment of uterine leiomyosarcoma Obstet Gynecol 1988, 71:845-50 2453004
7. Berchuck A Rubin SC Hoskins WJ Saigo PE Pierce VK Lewis JL Jr Treatment of endometrial stromal tumors Gynecol Oncol 1990, 36:60-5 2295453
8. Kempson RL Bari W Uterine sarcomas. Classification, diagnosis, and prognosis Hum Pathol 1970, 1:331-49 4330001
9. Brooks SE Zhan M Cote T Baquet CR Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999 Gynecol Oncol 2004, 93:204-8 15047237
10. Ali S Wells M Mixed Mullerian tumors of the uterine corpus: A review Int J Gynecol Cancer 1993, 3:1-11 11578316
11. Iwasa Y Haga H Konishi I Kobashi Y Higuchi K Katsuyama E Minamiguchi S Yamabe H Prognostic factors in uterine carcinosarcoma: A clinicopathologic study of 25 patients Cancer 1998, 82:512-9 9452269
12. Ramondetta L Bodurka D Deavers M Jhingran A Uterine Sarcomas M. D. Anderson Cancer Care Series, Gynecologic Cancer Springer. New York Eifel PJ, Gershenson DM, Kavanagh JJ, Silva EG 2006 125 147
13. Gadducci A Cosio S Romanini A Genazzani AR The management of patients with uterine sarcoma: A debated clinical challenge Crit Rev Oncol Hematol 2008, 65:129-42 17706430
14. Zelmanowicz A Hildesheim A Sherman ME Sturgeon SR Kurman RJ Barrett RJ Berman ML Mortel R Twiggs LB Wilbanks GD Brinton LA Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors Gynecol Oncol 1998, 69:253-7 9648597
15. McCluggage WG Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas Int J Gynecol Cancer 2002, 12:687-90 12445244
16. Vrzic-Petronijevic S Likic-Ladjevic I Petronijevic M Argirovic R Ladjevic N Diagnosis and surgical therapy of uterine sarcoma Acta Chir Iugosl 2006, 53:67-72 17338203
17. Benoit L Arnould L Cheynel N Goui S Collin F Fraisse J Cuisenier J The role of surgery and treatment trends in uterine sarcoma Eur J Surg Oncol 2005, 31:434-42 15837053
18. Major FJ Blessing JA Silverberg SG Morrow CP Creasman WT Currie JL Yordan E Brady MF Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study Cancer 1993, 71(4 Suppl):1702-9 8381710
19. Kanjeekal S Chambers A Fung MF Verma S Systemic therapy for advanced uterine sarcoma: A systematic review of the literature Gynecol Oncol 2005, 97:624-37 15863170
20. Akahira J Tokunaga H Toyoshima M Takano T Nagase S Yoshinaga K Tase T Wada Y Ito K Niikura H Yamada H Sato A Sasano H Yaegashi N Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: A comparison with uterine endometrial adenocarcinoma Oncology 2006, 71:333-40 17690557
21. Chauveinc L Deniaud E Plancher C Sastre X Amsani F de la Rochefordiere A Rozemberg H Clough KB Uterine sarcomas: The Curie Institut experience. Prognosis factors and adjuvant treatments Gynecol Oncol 1999, 72:232-7 10021306
22. Vaidya AP Horowitz NS Oliva E Halpern EF Duska LR Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma Gynecol Oncol 2006, 103:684-7 16797683
23. El Husseiny G Al Bareedy N Mourad WA Mohamed G Shoukri M Subhi J Ezzat A Prognostic factors and treatment modalities in uterine sarcoma Am J Clin Oncol 2002, 25:256-60 12040283
24. Kokawa K Nishiyama K Ikeuchi M Ihara Y Akamatsu N Enomoto T Ishiko O Motoyama S Fujii S Umesaki N Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990-2003) Int J Gynecol Cancer 2006, 16:1358-63 16803530
25. Temkin SM Hellmann M Lee YC Abulafia O Early-stage carcinosarcoma of the uterus: The significance of lymph node count Int J Gynecol Cancer 2007, 17:215-9 17291256
26. Nemani D Mitra N Guo M Lin L Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: A SEER analysis Gynecol Oncol 2008 18674808
27. Reed NS The management of uterine sarcomas Clin Oncol (R Coll Radiol) 2008, 20:470-8 18572394
28. Hornback NB Omura G Major FJ Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma Int J Radiat Oncol Biol Phys 1986, 12:2127-30 3793549
29. Dusenbery KE Potish RA Argenta PA Judson PL On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus Am J Clin Oncol 2005, 28:295-300 15923804
30. Wright JD Seshan VE Shah M Schiff PB Burke WM Cohen CJ Herzog TJ The role of radiation in improving survival for early-stage carcinosarcoma and leiomyosarcoma Am J Obstet Gynecol 2008
31. Callister M Ramondetta LM Jhingran A Burke TW Eifel PJ Malignant mixed Müllerian tumors of the uterus: Analysis of patterns of failure, prognostic factors, and treatment outcome Int J Radiat Oncol Biol Phys 2004, 58:786-96 14967435
32. Clayton Smith D Kenneth Macdonald O Gaffney DK The impact of adjuvant radiation therapy on survival in women with uterine carcinosarcoma Radiother Oncol 2008, 88:227-32 18160157
33. Wolfson AH Brady MF Rocereto T Mannel RS Lee YC Futoran RJ Cohn DE Ioffe OB A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus Gynecol Oncol 2007, 107:177-85 17822748
34. Reed NS Mangioni C Malmström H Scarfone G Poveda A Pecorelli S Tateo S Franchi M Jobsen JJ Coens C Teodorovic I Vergote I Vermorken JB European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874) Eur J Cancer 2008, 44:808-18 18378136
35. Sutton G Kauderer J Carson LF Lentz SS Whitney CW Gallion H Gynecologic Oncology Group Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: A Gynecologic Oncology Group study Gynecol Oncol 2005, 96:630-4 15721404
36. Makker V Abu-Rustum NR Alektiar KM Aghajanian CA Zhou Q Iasonos A Hensley M A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma Gynecol Oncol 2008, 111:249-54 18755503
37. Cicin I Saip P Eralp Y Selam M Topuz S Ozluk Y Aydin Y Topuz E Ovarian carcinosarcomas: Clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum Gynecol Oncol 2008, 108:136-40 17936342
38. Wilkinson N Rollason TP Recent advances in the pathology of smooth muscle tumours of the uterus Histopathology 2001, 39:331-41 11683931
39. Zaloudek C Hendrickson MR Mesenchymal tumors of the uterus Blaustein's pathology of the female genital tract New York: Springer-Verlag, Inc Kurman RJ 2002, 561-615
40. Leibsohn S d'Ablaing G Mishell DR Jr Schlaerth JB Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas Am J Obstet Gynecol 1990, 16: 968-74 discussion 974-6. 2327466
41. Akhan SE Yavuz E Tecer A Iyibozkurt CA Topuz S Tuzlali S Bengisu E Berkman S The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study Gynecol Oncol 2005, 99:36-42 15992918
42. Leitao MM Soslow RA Nonaka D Olshen AB Aghajanian C Sabbatini P Dupont J Hensley M Sonoda Y Barakat RR Anderson S Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma Cancer 2004, 101:1455-62 15316901
43. Gadducci A Landoni F Sartori E Zola P Maggino T Lissoni A Bazzurini L Arisio R Romagnolo C Cristofani R Uterine leiomyosarcoma: Analysis of treatment failures and survival Gynecol Oncol 1996, 62:25-32 8690287
44. Giuntoli RL 2nd Metzinger DS DiMarco CS Cha SS Sloan JA Keeney GL Gostout BS Retrospective review of 208 patients with leiomyosarcoma of the uterus: Prognostic indicators, surgical management, and adjuvant therapy Gynecol Oncol 2003, 89:460-9 12798712
45. Gard GB Mulvany NJ Quinn MA Management of uterine leiomyosarcoma in Australia Aust N Z J Obstet Gynaecol 1999, 39:93-8 10099759
46. Bodner K Bodner-Adler B Kimberger O Czerwenka K Leodolter S Mayerhofer K Evaluating prognostic parameters in women with uterine leiomyosarcoma. A clinicopathologic study J Reprod Med 2003, 48:95-100 12621792
47. Cantisani V Mortele KJ Kalantari BN Glickman JN Tempany C Silverman SG Vaginal metastasis from uterine leiomyosarcoma. Magnetic resonance imaging features with pathological correlation J Comput Assist Tomogr 2003, 27:805-9 14501374
48. Eloy JA Mortensen M Gupta S Lewis MS Brett EM Genden EM Metastasis of uterine leiomyosarcoma to the thyroid gland: Case report and review of the literature Thyroid 2007, 17:1295-7 17988195
49. Elhammady MS Manzano GR Lebwohl N Levi AD Leiomyosarcoma metastases to the spine. Case series and review of the literature J Neurosurg Spine 2007, 6:178-83 17330589
50. Hensley ML Ishill N Soslow R Larkin J Abu-Rustum N Sabbatini P Konner J Tew W Spriggs D Aghajanian CA Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study Gynecol Oncol 2009, 112:563-7 19135708
51. Diesing D Cordes T Finas D Löning M Mayer K Diedrich K Friedrich M Endometrial stromal sarcomas - a retrospective analysis of 11 patients Anticancer Res 2006, 26:655-61 16739335
52. Gadducci A Sartori E Landoni F Zola P Maggino T Urgesi A Lissoni A Losa G Fanucchi A Endometrial stromal sarcoma: Analysis of treatment failures and survival Gynecol Oncol 1996, 63:247-53 8910635
53. Oláh KS Gee H Blunt S Dunn JA Kelly K Chan KK Retrospective analysis of 318 cases of uterine sarcoma Eur J Cancer 1991, 27:1095-9 1835616
54. Li N Wu LY Zhang HT An JS Li XG Ma SK Treatment options in stage I endometrial stromal sarcoma: A retrospective analysis of 53 cases Gynecol Oncol 2008, 108:306-11 18061249
55. Amant F Vergote I Moerman P The classification of a uterine sarcoma as 'high-grade endometrial stromal sarcoma' should be abandoned Gynecol Oncol 2004, 95:412-3 author reply 413. 15491769
56. Chang KL Crabtree GS Lim-Tan SK Kempson RL Hendrickson MR Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases Am J Surg Pathol 1990, 14:415-38 2327549
57. Kim L Choi SJ Park IS Han JY Kim JM Chu YC Kim KR Endometrial stromal sarcoma of the small bowel Ann Diagn Pathol 2008, 12:128-33 18325474
58. Kurihara S Oda Y Ohishi Y Iwasa A Takahira T Kaneki E Kobayashi H Wake N Tsuneyoshi M Endometrial stromal sarcomas and related high-grade sarcomas: Immunohistochemical and molecular genetic study of 31 cases Am J Surg Pathol 2008, 32:1228-38 18580489
59. Balleine RL Earls PJ Webster LR Mote PA deFazio A Harnett PR Clarke CL Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma Int J Gynecol Pathol 2004, 23:138-44 15084842
60. Al-Salam S El-Terifi H Ghazal-Aswad S Low-grade endometrial stromal sarcoma with sex cord-like differentiation metastatic to the thoracic spines APMIS 2006, 114:651-5 16948819
61. Moinfar F Regitnig P Tabrizi AD Denk H Tavassoli FA Expression of androgen receptors in benign and malignant endometrial stromal neoplasms Virchows Arch 2004, 444:410-4 15007645
62. Chu MC Mor G Lim C Zheng W Parkash V Schwartz PE Low-grade endometrial stromal sarcoma: Hormonal aspects Gynecol Oncol 2003, 90:170-6 12821359
63. Reich O Regauer S Urdl W Lahousen M Winter R Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas Br J Cancer 2000, 82:1030-4 10737385
64. Navarro D Cabrera JJ León L Chirino R Fernández L López A Rivero JF Fernández P Falcón O Jiménez P et al Endometrial stromal sarcoma expression of estrogen receptors, progesterone receptors and estrogen-induced srp27 (24 K) suggests hormone responsiveness J Steroid Biochem Mol Biol 1992, 41:589-96 1562530
65. Sabini G Chumas JC Mann WJ Steroid hormone receptors in endometrial stromal sarcomas. A biochemical and immunohistochemical study Am J Clin Pathol 1992, 97:381-6 1371902
66. Kir G Cetiner H Karateke A Gurbuz A Bulbul D Utility of MIB-1 and estrogen and progesterone receptor in distinguishing between endometrial stromal sarcomas and endometrial stromal nodules, highly cellular leiomyomas Int J Gynecol Cancer 2005, 15:337-42 15823122
67. Zhu XQ Shi YF Cheng XD Zhao CL Wu YZ Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma Gynecol Oncol 2004, 92:71-9 14751141
68. Popiolek D Yee H Levine P Vamvakas E Demopoulos RI MIB1 as a possible predictor of recurrence in low-grade endometrial stromal sarcoma of the uterus Gynecol Oncol 2003, 90:353-7 12893199
69. Weitmann HD Kucera H Knocke TH Pötter R Surgery and adjuvant radiation therapy of endometrial stromal sarcoma Wien Klin Wochenschr 2002, 114:44-9 12407935
70. Weitmann HD Knocke TH Kucera H Pötter R Radiation therapy in the treatment of endometrial stromal sarcoma Int J Radiat Oncol Biol Phys 2001, 49:739-48 11172957
71. Riopel J Plante M Renaud MC Roy M Têtu B Lymph node metastases in low-grade endometrial stromal sarcoma Gynecol Oncol 2005, 96:402-6 15661228
72. Reich O Winter R Regauer S Should lymphadenectomy be performed in patients with endometrial stromal sarcoma? Gynecol Oncol 2005, 97:982-3 15944001
73. Pink D Lindner T Mrozek A Kretzschmar A Thuss-Patience PC Dörken B Reichardt P Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: Single center experience with 10 cases and review of the literature Gynecol Oncol 2006, 101:464-9 16368128
74. Berceanu S Pǎtraşcu A Berceanu C Tica AA Bǎdulescu A Endometrial stromal sarcoma: Clinico-pathological report of four cases and review of the literature Rom J Morphol Embryol 2008, 49:251-5 18516335
75. Ihnen M Mahner S Jänicke F Schwarz J Current treatment options in uterine endometrial stromal sarcoma: Report of a case and review of the literature Int J Gynecol Cancer 2007, 17:957- 63 17359294
76. Ishiko O Wakasa K Honda K Nakajima S Ogita S Excellent results of postoperative radiotherapy for endometrial stromal sarcoma of low-grade malignancy Gynecol Obstet Invest 2000, 49:214-6 10729766
77. Livi L Andreopoulou E Shah N Paiar F Blake P Judson I Harmer C Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998 Clin Oncol (R Coll Radiol) 2004, 16:261-8 15214650
78. Reich O Regauer S Hormonal therapy of endometrial stromal sarcoma Curr Opin Oncol 2007, 19:347-52 17545798
79. Schindler AE Campagnoli C Druckmann R Huber J Pasqualini JR Schweppe KW Thijssen JH Classification and pharmacology of progestins Maturitas 2003, 46(Suppl 1):S7-S16 14670641
80. Maluf FC Sabbatini P Schwartz L Xia J Aghajanian C Endometrial stromal sarcoma: Objective response to letrozole Gynecol Oncol 2001, 82:384-388 11531300
81. Spano JP Soria JC Kambouchner M Piperno-Neuman S Morin F Morere JF Martin A Breau JL Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma Med Oncol 2003, 20:87-93 12665689
82. Leunen M Breugelmans M De Sutter P Bourgain C Amy JJ Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole Gynecol Oncol 2004, 95:769-771 15582003
83. Leiser AL Hamid AM Blanchard R Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor Gynecol Oncol 2004, 94:567-571 15297205
84. Scribner DR Jr Walker JL Low-grade endometrial stromal sarcoma preoperative treatment with Depo-Lupron and Megace Gynecol Oncol 1998, 71:458-460 9887250
85. Mesia AF Demopoulos RI Effects of leuprolide acetate on low-grade endometrial stromal sarcoma Am J Obstet Gynecol 2000, 182:1140-1141 10819848
86. Burke C Hickey K Treatment of endometrial stromal sarcoma with a gonadotropin-releasing hormone analogue Obstet Gynecol 2004, 104:1182-1184 15516445
87. Reich O Regauer S Estrogen replacement therapy and tamoxifen are contraindicated in patients with endometrial stromal sarcoma Gynecol Oncol 2006, 102:413-414 16712906
88. De Fusco PA Gaffey TA Malkasian GD Jr Long HJ Cha SS Endometrial stromal sarcoma: Review of Mayo Clinic experience, 1945-1980 Gynecol Oncol 1989, 35:8-14 2792908
89. Bramwell V Rouesse J Steward W Santoro A Schraffordt-Koops H Buesa J Ruka W Priario J Wagener T Burgers M et al Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma - reduced local recurrence but no improvement in survival: A study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group J Clin Oncol 1994, 12:1137-49 8201375
90. Frustaci S Gherlinzoni F De Paoli A Bonetti M Azzarelli A Comandone A Olmi P Buonadonna A Pignatti G Barbieri E Apice G Zmerly H Serraino D Picci P Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: Results of the Italian randomized cooperative trial J Clin Oncol 2001, 19:1238-47 11230464
91. Frustaci S De Paoli A Bidoli E La Mura N Berretta M Buonadonna A Boz G Gherlinzoni F Ifosfamide in the adjuvant therapy of soft tissue sarcomas Oncology 2003, 65(Suppl 2):80-4 14586155
92. Sarcoma Meta-Analysis Collaboration (SMAC) Adjuvant, chemotherapy for localised respectable soft tissue sarcoma in adults Cohchrane Database Syst Rev 2000 CD001419
93. Hannigan EV Freedman RS Rutledge FN Adjuvant chemotherapy in early uterine sarcoma Gynecol Oncol 1983, 15:56-64 6401640
94. Buchsbaum HJ Lifshitz S Blythe JG Prophylactic chemotherapy in stages I and II uterine sarcoma Gynecol Oncol 1979, 8:346-8 511000
95. van Nagell JR Jr Hanson MB Donaldson ES Gallion HH Adjuvant vincristine, dactinomycin, and cyclophosphamide therapy in stage I uterine sarcomas. A pilot study Cancer 1986, 57:1451-4 3948125
96. Hempling RE Piver MS Baker TR Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trial Am J Clin Oncol 1995, 18:282-6 7625366
97. Odunsi K Moneke V Tammela J Ghamande S Seago P Driscoll D Marchetti D Baker T Lele S Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: Results of long-term follow-up Int J Gynecol Cancer 2004, 14:659-64 15304162
98. Kushner DM Webster KD Belinson JL Rybicki LA Kennedy AW Markman M Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma Gynecol Oncol 2000, 78:221-7 10926807
99. Pautier P Rey A Haie-Meder C Kerbrat P Dutel JL Gesta P Bryard F Morice P Duvillard P Lhommé C Adjuvant chemotherapy with cisplatin, ifosfamide, and doxorubicin followed by radiotherapy in localized uterine sarcomas: Results of a case-control study with radiotherapy alone Int J Gynecol Cancer 2004, 14:1112-7 15571617
100. Omura GA Blessing JA Major F Lifshitz S Ehrlich CE Mangan C Beecham J Park R Silverberg S A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: A Gynecologic Oncology Group Study J Clin Oncol 1985, 3:1240-5 3897471
101. Resnik E Chambers SK Carcangiu ML Kohorn EI Schwartz PE Chambers JT A phase II study of etoposide, cisplatin, and doxorubicin chemotherapy in mixed müllerian tumors (MMT) of the uterus Gynecol Oncol 1995, 56:370-5 7705670
102. Manolitsas TP Wain GV Williams KE Freidlander M Hacker NF Multimodality therapy for patients with clinical Stage I and II malignant mixed Müllerian tumors of the uterus Cancer 2001, 91:1437-43 11301390
103. Cassier PA Dufresne A Blay J-Y Fayette J Trabectedin and its potential in the treatment of soft tissue sarcoma Ther Clin Risk Manag 2008, 4:109-116 2503645 18728699
104. Wu TI Chang TC Hsueh S Hsu KH Chou HH Huang HJ Lai CH Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma Gynecol Oncol 2006, 100:166-72 16182349
105. Piver MS Lele SB Marchetti DL Emrich LJ Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas J Surg Oncol 1988, 38:233-9 3045423
106. Sartori E Bazzurini L Gadducci A Landoni F Lissoni A Maggino T Zola P La Face B Carcinosarcoma of the uterus: A clinicopathological multicenter CTF study Gynecol Oncol 1997, 67:70-5 9345359